(99m)Tc-DTPA uptake in clear-cell renal carcinoma metastases.
Nuclear Medicine Unit, Istituto Clinico Humanitas IRCCS, Rozzano, Italy. lidija.antunovic@cancercenter.humanitas.it
L
L
Antunovic
B
B
Franklin-Bezerra
M
M
Rodari
G
G
Pepe
A
A
Chiti
D000310:Adrenal Gland Neoplasms / Q000098:blood supply / Q000000981:diagnostic imaging / Q000556:secondary*; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000098:blood supply / Q000000981:diagnostic imaging / Q000556:secondary* / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology* / Q000628:therapy; D008297:Male; D019042:Muscle Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary*; D009389:Neovascularization, Pathologic / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D016284:Technetium Tc 99m Pentetate / Q000493:pharmacokinetics; D014057:Tomography, X-Ray Computed
D019275:Radiopharmaceuticals; D016284:Technetium Tc 99m Pentetate